Safety Tips
- Meet in a safe, public place
- Check the item before buying
- Pay only after collecting the item
Description
Trodelvy (sacituzumab govitecan) is approved for treating triple-negative breast cancer (TNBC) and HR+/HER2- metastatic breast cancer (mBC). The Trodelvy availability in India remains limited as it is not approved in India. The medicine is not currently approved by the CDSCO. Access for patients in India may be possible in specific circumstances through the country’s legal provisions for importing unapproved or unavailable medicines. Under these provisions—commonly referred to as the Named Patient Program (NPP)—a licensed treating physician may submit a request on behalf of an individual patient. This process requires a valid medical prescription, documented clinical need, and the necessary import authorizations (such as Form 12A or 12B) from the relevant regulatory authorities.
Indian Pharma Network (IPN) facilitates administrative and logistical support for healthcare providers pursuing this pathway. This includes coordinating the required documentation, assisting with import permissions, and arranging shipment from authorized international sources. All activities are carried out in alignment with applicable laws and regulations. Kindly call/WhatsApp: + 91-9310090915 to know how we can help you.
Indian Pharma Network (IPN) facilitates administrative and logistical support for healthcare providers pursuing this pathway. This includes coordinating the required documentation, assisting with import permissions, and arranging shipment from authorized international sources. All activities are carried out in alignment with applicable laws and regulations. Kindly call/WhatsApp: + 91-9310090915 to know how we can help you.
Location
Noida, Uttar Pradesh